Back to Journals » Drug Design, Development and Therapy » Volume 11

Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models

Total article views   HTML views PDF downloads Totals
27,045 Dovepress* 18,517+ 1,503 20,020
PubMed Central* 8,528 635 9,163
Totals 27,045 2,138 29,183
*Since 11 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 3 4

View citations on PubMed Central and Google Scholar